Evidence map›Paper›PMID 34858938›Full record

ArticleFrontiers in public health2021

Bo Wang, Xinlong He, Feng Lu, Yajuan Li, Yuerong Wang, Min Zhang, Ying Huang, Jinxing Xia

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Biofilm-related characteristics ofFrontiers in cellular and infection microbiology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Antifungal susceptibility, molecular epidemiology, and clinical risk factors ofFrontiers in cellular and infection microbiology · 2024
    Article
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Bo WangDepartment of Clinical Laboratory, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Xinlong HeDepartment of Pathogen Biology, School of Medicine, Yangzhou University, Yangzhou, China.
Feng LuDepartment of Pathogen Biology, School of Medicine, Yangzhou University, Yangzhou, China.
Yajuan LiDepartment of Clinical Laboratory, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Yuerong WangDepartment of Clinical Laboratory, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Min ZhangDepartment of Clinical Laboratory, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Ying HuangDepartment of Clinical Laboratory, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Jinxing XiaDepartment of Clinical Laboratory, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
First Affiliated Hospital of Anhui Medical University · CNAnhui Medical University · CNYangzhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CandidaCandidiasis, InvasiveAntifungal AgentsAzolesCandida tropicalisDrug Resistance, FungalHumansIntensive Care UnitsMicrobial Sensitivity TestsRisk FactorsAntifungal AgentsAzolescandidiasisdrug resistance mechanismepidemiologyintensive care unit (ICU)risk factors

Identifiers

PMID34858938
PMCPMC8632017
OpenAlexW3214295738

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.